Prostate cancer drugs from AstraZeneca Plc, Watson Pharmaceuticals Inc. and others don’t increase the risk of heart attacks in men with no history of the disease, a study said, contradicting earlier reports.
Prostate cancer drugs from AstraZeneca Plc, Watson Pharmaceuticals Inc. and others don’t increase the risk of heart attacks in men with no history of the disease, a study said, contradicting earlier reports.